Urenco Finance N.V. Urenco Finance N.V. Result of Tender Offer (3898N)
17 January 2019 - 9:03PM
UK Regulatory
TIDM44ZP
RNS Number : 3898N
Urenco Finance N.V.
17 January 2019
URENCO Finance N.V. Announces Results of its Tender Offer in
respect of its
EUR750,000,000 2.50 per cent. Notes due 2021
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT
QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE
MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU)
596/2014
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO
ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS
TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN
ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA
ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF
COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO
RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT
17 January 2019. URENCO Finance N.V. (the Company) announces
today the results of its invitation to holders of its
EUR750,000,000 2.50 per cent. Notes due 2021 (ISIN: XS1032164607)
(the Notes) to tender their Notes for purchase by the Company for
cash (the Offer).
The Offer was announced on 9 January 2019, and was made on the
terms and subject to the conditions contained in the tender offer
memorandum dated 9 January 2019 (the Tender Offer Memorandum)
prepared by the Company. Capitalised terms used in this
announcement but not defined have the meanings given to them in the
Tender Offer Memorandum.
The Expiration Deadline for the Offer was 5.00 p.m. (CET) on 16
January 2019.
As at the Expiration Deadline, EUR215,600,000 in aggregate
nominal amount of the Notes had been validly tendered for purchase
pursuant to the Offer.
The Company announces that it has decided to set the Final
Acceptance Amount at EUR215,600,000 in aggregate nominal amount of
Notes. Accordingly, the Company will accept for purchase all Notes
validly tendered pursuant to the Offer with no pro rata
scaling.
A summary of the results of the Offer appears below:
Description ISIN / Common Final Acceptance
of the Notes Code Amount Scaling Factor Purchase Price
---------------- -------------- ----------------- --------------- ---------------
EUR750,000,000 XS1032164607 EUR215,600,000 N/A 104.60 per
2.50 per cent. / 103216460 cent.
Notes due 2021
The Settlement Date in respect of those Notes accepted for
purchase is expected to be 22 January 2019. Following settlement of
the Offer, EUR534,400,000 in aggregate nominal amount of the Notes
will remain outstanding.
Barclays Bank PLC (Telephone: +44 20 3134 8515; Attention:
Liability Management Group; Email: eu.lm@barclays.com) and
Citigroup Global Markets Limited (Telephone: +44 20 7986 8969;
Attention: Liability Management Group; Email:
liabilitymanagement.europe@citi.com) are acting as Dealer Managers
for the Offer and Lucid Issuer Services Limited (Telephone: +44 20
7704 0880; Attention: David Shilson; Email: urenco@lucid-is.com) is
acting as Tender Agent.
This announcement is released by the Company and contains
information that qualified or may have qualified as inside
information for the purposes of Article 7 of the Market Abuse
Regulation (EU) 596/2014 (MAR), encompassing information relating
to the Offer described above. For the purposes of MAR and Article 2
of Commission Implementing Regulation (EU) 2016/1055, this
announcement is made by Gerard Tyler, Head of Group Treasury at
Urenco Limited.
LEI Number: 549300424FNJMWD3CO80
DISCLAIMER This announcement must be read in conjunction with
the Tender Offer Memorandum. No offer or invitation to acquire any
securities is being made pursuant to this announcement. The
distribution of this announcement and the Tender Offer Memorandum
in certain jurisdictions may be restricted by law. Persons into
whose possession this announcement and/or the Tender Offer
Memorandum comes are required by each of the Company, the Dealer
Managers and the Tender Agent to inform themselves about, and to
observe, any such restrictions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RTEEAEFXFEANEFF
(END) Dow Jones Newswires
January 17, 2019 05:03 ET (10:03 GMT)
Urenco 24 (LSE:44ZP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Urenco 24 (LSE:44ZP)
Historical Stock Chart
From Dec 2023 to Dec 2024